In early January 2026, Teleflex announced the past departure of Chairman, President and CEO Liam Kelly, appointed long-time ...

Teleflex announced today that Chair, President and CEO Liam Kelly is departing the company, effective immediately.

Teleflex has parted ways with CEO Liam Kelly and is putting a retired board member in charge of the company on an interim ...

Teleflex said the decision to move on from Kelly, who had been CEO since January 2018 and chairman since May 2022, is part of its shift to a more focused, higher-growth organization with the planned ...

Stuart Randle Appointed Interim President and CEOBoard Initiates Search for Permanent CEODr. Stephen Klasko Appointed Chairman of the ...

Teleflex announced a major leadership transition effective January 7–8, 2026, with long-time Chairman, President and CEO Liam Kelly departing and board member Stuart Randle, a veteran medical device ...

Teleflex shares fell after the medical technology company said it was parting ways with its chief executive officer, and cut its outlook for the year. The stock was down 13% to $110.36 in late morning ...

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” investor letter for the first quarter of 2025. A copy of the letter can be downloaded here. The first quarter of ...

Teleflex Incorporated (NYSE:TFX), a global provider of medical technologies with a market capitalization of $7.9 billion, has seen its stock price touch a 52-week low, reaching $170.07. According to ...

RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Teleflex on January 7 and set a price target of $135.00. The company’s shares closed yesterday at $126.53.

With this transaction, Intersurgical will integrate the Acute Care and Interventional Urology product ranges, technical ...

Teleflex Incorporated has announced a contract with Vizient, Inc. for the supply of its Central Venous Access Catheters and Arterial Catheters, effective January 1, 2025. Vizient, the largest provider ...